2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China.

Authors: Sheng, Qilian^1,2,3,4 (AUTHOR), Sun, Yanan^1,2,3,4 (AUTHOR), Zhai, Ruyi^1,2,3,4 (AUTHOR), Fan, Xintong^1,2,3,4 (AUTHOR), Ying, Yue^1,2,3,4 (AUTHOR), Kong, Xiangmei^1,2,3,4 (AUTHOR) kongxm95@163.com

Source: Ocular Immunology & Inflammation. Jul2024, Vol. 32 Issue 5, p505-512. 8p.

Subject Terms: *GANCICLOVIR, *GLAUCOMA, *CORTICOSTEROIDS, *CYTOMEGALOVIRUS diseases, *OPHTHALMIC drugs

Geographic Terms: CHINA

The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System.

Authors: Pallasch, Fabian Bernhard^1,2 (AUTHOR) fabian.pallasch@uniklinik-freiburg.de, Freytag, Vera¹ (AUTHOR), Kriegs, Malte^3,4 (AUTHOR), Gatzemeier, Dennis⁵ (AUTHOR), Mair, Thomas⁵ (AUTHOR), Voss, Hannah⁵ (AUTHOR), Riecken, Kristoffer⁶ (AUTHOR), Dawood, Mona⁷ (AUTHOR), Fehse, Boris⁶ (AUTHOR), Efferth, Thomas⁷ (AUTHOR), Schlüter, Hartmut⁵ (AUTHOR), Schumacher, Udo^1,8 (AUTHOR)

Source: Cancers. Jun2024, Vol. 16 Issue 12, p2278. 22p.

Subject Terms: *MITOGEN-activated protein kinases, *GANCICLOVIR, *DISEASE vectors, *HERPESVIRUSES, *GENETIC engineering, *CELL proliferation, *APOPTOSIS, *TREATMENT effectiveness, *LYMPHOMAS, *DESCRIPTIVE statistics, *CELL lines, *GENE expression, *LEUKEMIA, *CANCER chemotherapy, *MESSENGER RNA, *GENE expression profiling, *PROTEOMICS, *DISEASE susceptibility, *TRANSFERASES, *HISTOLOGY, *SEQUENCE analysis, *SIGNAL peptides, *PHARMACODYNAMICS

Folate-Targeted Nanocarriers Co-Deliver Ganciclovir and miR-34a-5p for Combined Anti-KSHV Therapy.

Authors: Li, Fangling^1,2 (AUTHOR) lifanglingcdd@sina.com, Cao, Dongdong¹ (AUTHOR) caodongd@shzu.edu.cn, Gu, Wenyi³ (AUTHOR) w.gu@uq.edu.au, Li, Dongmei¹ (AUTHOR) cuilin@shzu.edu.cn, Liu, Zhiyong² (AUTHOR) lidongmei@shzu.edu.cn, Cui, Lin¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2932. 19p.

Subject Terms: *KAPOSI'S sarcoma-associated herpesvirus, *GANCICLOVIR, *NANOCARRIERS, *FOLIC acid, *GENE expression, *NUCLEIC acids

Development and Validation of an HPLC-UV Method for the Quantification of Acyclovir and Ganciclovir in the Plasma of Pediatric Immunocompromised Patients.

Authors: Franzin, Martina¹ (AUTHOR) martina.franzin@burlo.trieste.it, Ruoso, Rachele¹ (AUTHOR), Del Savio, Rossella¹ (AUTHOR), Addobbati, Riccardo¹ (AUTHOR) riccardo.addobbati@burlo.trieste.it

Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2685. 12p.

Subject Terms: *IMMUNOCOMPROMISED patients, *GANCICLOVIR, *ACYCLOVIR, *DRUG monitoring, *CYTOMEGALOVIRUS diseases, *BLOOD coagulation factor VIII

Nano-emulsomes for back of the eye delivery of Ganciclovir: formulation optimization, characterization & in vitro/in vivo evaluation.

Authors: Kapadia, Rakhee¹ (AUTHOR), Jain, Mahendra¹ (AUTHOR), Patel, Dipak² (AUTHOR), Devkar, Ranjitsinh² (AUTHOR), Sawant, Krutika¹ (AUTHOR)

Source: Pharmaceutical Development & Technology. Jul2023, Vol. 28 Issue 6, p535-546. 12p.

Subject Terms: Slit lamp microscopy, Ganciclovir, Confocal microscopy, Skin permeability, Factorial experiment designs, Cell lines

Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis.

Authors: Katada, Yoshiki^1,2 (AUTHOR) katada@kuhp.kyoto-u.ac.jp, Nakagawa, Shunsaku¹ (AUTHOR), Nagao, Miki^2,3 (AUTHOR), Umemura, Keisuke¹ (AUTHOR), Itohara, Kotaro¹ (AUTHOR), Nishikawa, Asami^1,2 (AUTHOR), Hashi, Sachiyo¹ (AUTHOR), Katsube, Yurie¹ (AUTHOR), Hira, Daiki¹ (AUTHOR), Ohsumi, Akihiro⁴ (AUTHOR), Nakajima, Daisuke⁴ (AUTHOR), Date, Hiroshi⁴ (AUTHOR), Terada, Tomohiro¹ (AUTHOR)

Source: Transplant Infectious Disease. Dec2023, Vol. 25 Issue 6, p1-9. 9p.

Subject Terms: *LUNG transplantation, *GANCICLOVIR, *VALGANCICLOVIR, *LEUCOPENIA, *RECEIVER operating characteristic curves

Cytomegalovirus Infection in Patient with Clear Cell Renal Cell Carcinoma.

Authors: Rinaldi, Ikhwan¹ (AUTHOR), Muthalib, Abdul¹ (AUTHOR), Sutandar, Januar Widodo² (AUTHOR), Kuncoro, Hendro Adi³ (AUTHOR), Harsono, Bambang Irawan⁴ (AUTHOR), Susanto, Nelly⁵ (AUTHOR), Setiawan, Tjondro⁵ (AUTHOR), Winston, Kevin⁶ (AUTHOR), Dewantara, Idham Rafly⁶ (AUTHOR), Amin, Ihya Fakhrurizal⁶ (AUTHOR), Shufiyani, Yuli Maulidiya⁶ (AUTHOR)

Source: Case Reports in Medicine. 11/13/2023, p1-6. 6p.

Subject Terms: *CYTOMEGALOVIRUS disease diagnosis, *GANCICLOVIR, *RENAL cell carcinoma, *RAPAMYCIN, *CYTOMEGALOVIRUS diseases, *PROTEIN-tyrosine kinase inhibitors, *VALGANCICLOVIR, *EVEROLIMUS, *POLYMERASE chain reaction

Safety and efficacy of weight‐based ganciclovir dosing strategies in overweight/obese patients.

Authors: Miller, William¹ (AUTHOR) bjm3994@gmail.com, January, Spenser² (AUTHOR), Klaus, Jeff² (AUTHOR), Neuner, Elizabeth² (AUTHOR), Pande, Anupam³ (AUTHOR), Krekel, Tamara² (AUTHOR)

Source: Transplant Infectious Disease. Oct2023, Vol. 25 Issue 5, p1-9. 9p.

Subject Terms: *GANCICLOVIR, *POLYMERASE chain reaction, *OBESITY, *BODY weight, *FEBRILE neutropenia

Comparison of two different intravitreal treatment regimens combined with systemic antiviral therapy for cytomegalovirus retinitis in patients with AIDS.

Authors: Liang, Xuemei¹ (AUTHOR), An, Hongmei¹ (AUTHOR), He, Huawei² (AUTHOR), Shen, Baiyun¹ (AUTHOR), Ou, Zuguo¹ (AUTHOR), Li, Li¹ (AUTHOR) lxmyanke@163.com

Source: AIDS Research & Therapy. 7/14/2023, Vol. 20 Issue 1, p1-7. 7p.

Subject Terms: *CYTOMEGALOVIRUS retinitis, *GANCICLOVIR, *DRUG efficacy, *INJECTIONS, *INTRAOCULAR drug administration, *RANDOMIZED controlled trials, *COMPARATIVE studies, *PRE-tests & post-tests, *BLIND experiment, *DESCRIPTIVE statistics, *VISUAL acuity, *RESEARCH funding, *STATISTICAL sampling, *AIDS patients, *AIDS, *LONGITUDINAL method, *EVALUATION, *DISEASE complications

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir.

Authors: Yang, Wenyu^1,2 (AUTHOR) 21211030109@m.fudan.edu.cn, Mak, Wenyao¹ (AUTHOR) makwenyao@gmail.com, Gwee, Amanda^3,4,5 (AUTHOR) amanda.gwee@rch.org.au, Gu, Meng^1,2 (AUTHOR) 20211030060@fudan.edu.cn, Wu, Yue⁶ (AUTHOR) wuyue161@163.com, Shi, Yufei¹ (AUTHOR) yufei_shi@fudan.edu.cn, He, Qingfeng¹ (AUTHOR) qf_he@fudan.edu.cn, Xiang, Xiaoqiang¹ (AUTHOR) xiangxq@fudan.edu.cn, Han, Bing² (AUTHOR) hbshcn@163.com, Zhu, Xiao¹ (AUTHOR) hbshcn@163.com

Source: Pharmaceutics. Jul2023, Vol. 15 Issue 7, p1801. 20p.

Subject Terms: *GANCICLOVIR, *VALGANCICLOVIR, *BODY surface area, *PHARMACOKINETICS, *CYTOMEGALOVIRUS diseases

A Case of Good Visual Outcome following Retinal Ganciclovir Toxicity.

Authors: Yien, Lai¹ (AUTHOR) yien_lai@nuhs.edu.sg, Zhang, Trisha¹ (AUTHOR), Yew Sen, Yuen¹ (AUTHOR)

Source: Ocular Immunology & Inflammation. Nov2023, Vol. 31 Issue 9, p1881-1883. 3p.

Subject Terms: *GANCICLOVIR, *DRUG overdose

Drugs That Mimic Hypoxia Selectively Target EBV-Positive Gastric Cancer Cells.

Authors: Cordes, Blue-leaf A.¹ (AUTHOR) bcordes@wisc.edu, Bilger, Andrea¹ (AUTHOR), Kraus, Richard J.¹ (AUTHOR), Ward-Shaw, Ella T.¹ (AUTHOR), Labott, Madeline R.¹ (AUTHOR), Lee, Shinhyo¹ (AUTHOR), Lambert, Paul F.¹ (AUTHOR), Mertz, Janet E.¹ (AUTHOR) mertz@oncology.wisc.edu

Source: Cancers. Mar2023, Vol. 15 Issue 6, p1846. 17p.

Subject Terms: *STOMACH tumors, *GANCICLOVIR, *DRUG approval, *DRUG efficacy, *XENOGRAFTS, *IN vivo studies, *ANIMAL experimentation, *LATENT infection, *GEMCITABINE, *RESEARCH funding, *CELL lines, *IRON overload, *EPSTEIN-Barr virus diseases, *HYPOXEMIA, *MICE

Company/Entity: UNITED States. Food & Drug Administration

Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with Sterile Water for Ophthalmic Administration: Formulation and Stability Study.

Authors: Leanpolchareanchai, Jiraporn¹ (AUTHOR), Tangteerakoon, Patamaporn² (AUTHOR), Supapsophon, Patcharin³ (AUTHOR), Sukavatcharin, Somsiri⁴ (AUTHOR), Simaroj, Pornchai⁴ (AUTHOR), Suksiriworapong, Jiraphong¹ (AUTHOR) jiraphong.suk@mahidol.edu

Source: Pharmaceutics. Jan2023, Vol. 15 Issue 1, p208. 17p.

Subject Terms: *HYDROCOLLOIDS, *GANCICLOVIR, *LOW density polyethylene, *PARTICULATE matter, *VIRUS diseases, *EYE drops

Design and optimization of ganciclovir solid dispersion for improving its bioavailability.

Authors: Gaber, Dalia A.^1,2 dr_daliaahmed@hotmail.com, Alnwiser, Manar A.³, Alotaibi, Nadia L.³, Almutairi, Rawan A.³, Alsaeed, Sumaih S.³, Abdoun, Siham A.¹, Alsubaiyel, Amal M.¹

Source: Drug Delivery. Dec2022, Vol. 29 Issue 1, p1836-1847. 12p.

Subject Terms: *DRUG solubility, *GANCICLOVIR, *BIOAVAILABILITY, *DISPERSION (Chemistry), *DIFFERENTIAL scanning calorimetry, *NANOPARTICLES, *ANTIVIRAL agents

Leveraging machine learning in limited sampling strategies for efficient estimation of the area under the curve in pharmacokinetic analysis: a review.

Authors: Alsultan, Abdullah, Aljutayli, Abdullah, Aljouie, Abdulrhman, Albassam, Ahmed, Woillard, Jean‑Baptiste

Source: European Journal of Clinical Pharmacology; Feb2025, Vol. 81 Issue 2, p183-201, 19p

Subject Terms: BIOLOGICAL models, RECEIVER operating characteristic curves, IMMUNOSUPPRESSIVE agents, PROBABILITY theory, STATISTICAL sampling, BLOOD collection, GANCICLOVIR, DRUG monitoring, VANCOMYCIN, PHARMACOKINETICS, MACHINE learning, INDIVIDUALIZED medicine, DATA quality, ALGORITHMS, RIFAMPIN, DAPTOMYCIN

Nanocomplex hyaluronic acid/ganciclovir@ZIF-8 for ganciclovir efficient delivery and targeted anti-KSHV treatment

Authors: Fangling Li, Chengjing Liu, Wenyi Gu, Qianhe Xu, Dongmei Li, Dongdong Cao, Zhiyong Liu

Source: Cancer Nanotechnology, Vol 16, Iss 1, Pp 1-20 (2025)

Subject Terms: Anti-KSHV treatment, Ganciclovir, Drug-carrying nanocomplex, pH-responsive drug release, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1868-6958; https://doaj.org/toc/1868-6966

Access URL: https://doaj.org/article/4db3501b0a504cd09a49857ce77899b1

Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report.

Authors: Paolucci, Stefania¹ (AUTHOR), Campanini, Giulia¹ (AUTHOR), Cassaniti, Irene¹ (AUTHOR), Tebaldi, Alessandra² (AUTHOR), Novazzi, Federica¹ (AUTHOR), Fratini, Alice¹ (AUTHOR), Meini, Antonella³ (AUTHOR), Girelli, Federica³ (AUTHOR), Palumbo, Laura³ (AUTHOR), Plebani, Alessandro³ (AUTHOR), Baldanti, Fausto^1,4 (AUTHOR) fausto.baldanti@unipv.it

Source: BMC Infectious Diseases. 9/23/2021, Vol. 21 Issue 1, p1-5. 5p.

Subject Terms: *GANCICLOVIR, *CYTOMEGALOVIRUSES, *GENETIC mutation, *CYTOMEGALOVIRUS diseases, *HETEROCYCLIC compounds, *CANCER relapse, *ANTIVIRAL agents, *ACETIC acid, *LIVER transplantation, *DRUG resistance in microorganisms, *PHARMACODYNAMICS

The Analysis of Dynamic Changes and Prognosis of Posner–Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy.

Authors: Sheng, Qilian^1,2,3 (AUTHOR), Zhai, Ruyi^1,2,3 (AUTHOR), Fan, Xintong^1,2,3 (AUTHOR), Kong, Xiangmei^1,2,3 (AUTHOR)

Source: Journal of Ophthalmology. 6/2/2021, p1-6. 6p.

Subject Terms: *GANCICLOVIR, *GLAUCOMA, *INTRAOCULAR pressure, *CONFIDENCE intervals, *IMMUNOGLOBULINS, *CYTOMEGALOVIRUS diseases, *ANTIVIRAL agents, *RETROSPECTIVE studies, *UVEITIS, *DESCRIPTIVE statistics, *ODDS ratio, *LONGITUDINAL method

Geographic Terms: CHINA

Dose banding of intravenous ganciclovir: Banding scheme proposal and audit of toxicity and efficiency.

Authors: Rodriguez‐Reyes, Montserrat¹ morodriguez@clinic.cat, López‐Cabezas, Carmen¹, Calvo‐Cidoncha, Elena¹, Soy‐Muner, Dolors^1,2

Source: Journal of Clinical Pharmacy & Therapeutics. Jun2021, Vol. 46 Issue 3, p767-771. 5p.

Subject Terms: *GANCICLOVIR, *INTRAVENOUS therapy, *HEMOGLOBINS, *TREATMENT effectiveness, *LEUKOCYTE count, *DESCRIPTIVE statistics, *GENETIC techniques, *DOSAGE forms of drugs, *PATIENT safety, *LONGITUDINAL method

Steroid-Dependency in Posner-Schlossman Syndrome: A Suggested Topical 2% Ganciclovir and Gradual Decrement of Topical Steroid Combination Therapy from Shanghai PSS Study.

Authors: Ying, Yue^1,2,3,4 (AUTHOR), Sun, Yanan^1,2,3,4 (AUTHOR), Sheng, Qilian^1,2,3,4 (AUTHOR), Zhai, Ruyi^1,2,3,4 (AUTHOR), Fan, Xintong^1,2,3,4 (AUTHOR), Kong, Xiangmei^1,2,3,4 (AUTHOR) kongxm95@163.com

Source: Ocular Immunology & Inflammation. Jul2024, Vol. 32 Issue 5, p513-519. 7p.

Subject Terms: *STEROID drugs, *OCULAR hypertension, *GANCICLOVIR, *GLAUCOMA, *CLINICAL trials, *IRIS (Eye)